Advertisement
Advertisement

STOK

STOK logo

Stoke Therapeutics, Inc. Common Stock

30.39
USD
Sponsored
-0.72
-2.31%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

30.66

+0.27
+0.88%

Stoke Therapeutics, Inc. Common Stock Profile

About

Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.

Info & Links

CEO

Ian F. Smith

Headquarters

45 WIGGINS AVENUE
BEDFORD, MA 01730, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.stoketherapeutics.com

Auditor

KPMG LLP

Share holders

8

Employees

170

Stoke Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.91B

Enterprise Value

1.75B

Enterprise Value/EBITDA(ttm)

-9.50

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

11.27

Price to Book(mrq)

5.70

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-3.73%

Profit Margin(ttm)

-1147.93%

Return on Equity(ttm)

-2.05%

Return on Invested Capital(ttm)

-3.65%

Return on Assets(ttm)

-1.75%

Income Statement

Revenue(ttm)

32.08M

Revenue Per Share(ttm)

0.52

Gross Profit(ttm)

32.08M

EBITDA(ttm)3

-184.52M

Net Income Available to Common(ttm)

-169.77M

Diluted EPS(ttm)

-0.12

Share Statistics

Beta (5Y Monthly)

1.22

52-Week Change

162.21%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

62.28M

Dividend Yield

0.00%

Float4

53.53M

% Held by Insiders

9.50%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

343.55M

Total Cash Per Share(mrq)

5.52

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.28%

Quick Ratio(mrq)

5.28%

Book Value Per Share(mrq)

5.98

Cash Flow

Operating Cash Flow Per Share(ytd)

0.77

Free Cash Flow(ytd)

44.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement